Produit | DCI | Dosage | Forme | Laboratoire |
---|---|---|---|---|
AFINITOR® | EVEROLIMUS | 10 mg | Comprimé | NOVARTIS PHARMA AG |
AFINITOR® | EVEROLIMUS | 5 mg | Comprimé | NOVARTIS PHARMA AG |
CYTOBLAISTIN | VINCRISTINE SULFATE | 10mg/10ml | Suspension injectable | CIPLA Limited |
CYTOCRISTIN | VINCRISTINE SULFATE | 1 mg | Suspension injectable | CIPLA Limited |
DACARBAZINE | DACARBAZINE | 200 mg | Suspension injectable | Serum Institute of India Ltd |
EPIRUBICIN HYDROCHLORIDE (LYOPHILISED) | EPIRUBICIN | 50 mg | Suspension injectable | Serum Institute of India Ltd |
FEMARA® | LETROZOLE | 2,5 mg | Comprimé pelliculé/Coated tablet | NOVARTIS PHARMA AG |
IFOS | IFOSAMIDE | 1 g | Suspension injectable | CIPLA Limited |
NEOFLUR | FLUOROURACIL | 50 mg | Suspension injectable | CIPLA Limited |
NEOFLUR | FLUOROURACIL | 50 mg | Suspension injectable | CIPLA Limited |
ONCODOX-10 | DOXORUBICIN HYDROCHLORIDE | Suspension injectable | CIPLA Limited | |
ZOLADEX | GOSERELINE ACETATE | 10,8 mg | Implant | ASTRAZENECA UK Ltd |
ZOLADEX | Goséréline acétate | 3,6 mg | Implant | ASTRAZENECA UK Ltd |